156 related articles for article (PubMed ID: 16873891)
21. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis.
Kuijpers TW; Maianski NA; Tool AT; Becker K; Plecko B; Valianpour F; Wanders RJ; Pereira R; Van Hove J; Verhoeven AJ; Roos D; Baas F; Barth PG
Blood; 2004 May; 103(10):3915-23. PubMed ID: 14764526
[TBL] [Abstract][Full Text] [Related]
22. Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome.
Angelini R; Russo S; Corcelli A; Lobasso S
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404345
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
[TBL] [Abstract][Full Text] [Related]
24. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
[TBL] [Abstract][Full Text] [Related]
25. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures.
Liu O; Chinni BK; Manlhiot C; Vernon HJ
Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445
[TBL] [Abstract][Full Text] [Related]
26. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update.
Barth PG; Valianpour F; Bowen VM; Lam J; Duran M; Vaz FM; Wanders RJ
Am J Med Genet A; 2004 May; 126A(4):349-54. PubMed ID: 15098233
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.
Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D
J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168
[TBL] [Abstract][Full Text] [Related]
28. Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV.
Corey RA; Harrison N; Stansfeld PJ; Sansom MSP; Duncan AL
Chem Sci; 2022 Nov; 13(45):13489-13498. PubMed ID: 36507170
[TBL] [Abstract][Full Text] [Related]
29. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
30. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.
Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286
[TBL] [Abstract][Full Text] [Related]
31. Interplay between cardiolipin and plasmalogens in Barth syndrome.
Bozelli JC; Epand RM
J Inherit Metab Dis; 2022 Jan; 45(1):99-110. PubMed ID: 34655242
[TBL] [Abstract][Full Text] [Related]
32. Seven functional classes of Barth syndrome mutation.
Whited K; Baile MG; Currier P; Claypool SM
Hum Mol Genet; 2013 Feb; 22(3):483-92. PubMed ID: 23100323
[TBL] [Abstract][Full Text] [Related]
33. Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome.
Angelini R; Lobasso S; Gorgoglione R; Bowron A; Steward CG; Corcelli A
J Lipid Res; 2015 Sep; 56(9):1787-94. PubMed ID: 26144817
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis.
Danos M; Taylor WA; Hatch GM
Biochem Cell Biol; 2008 Feb; 86(1):11-20. PubMed ID: 18364741
[TBL] [Abstract][Full Text] [Related]
35. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation.
Taylor WA; Mejia EM; Mitchell RW; Choy PC; Sparagna GC; Hatch GM
PLoS One; 2012; 7(11):e48628. PubMed ID: 23152787
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in TAZ causes mitochondrial respiratory chain disorder without cardiomyopathy.
Borna NN; Kishita Y; Ishikawa K; Nakada K; Hayashi JI; Tokuzawa Y; Kohda M; Nyuzuki H; Yamashita-Sugahara Y; Nasu T; Takeda A; Murayama K; Ohtake A; Okazaki Y
J Hum Genet; 2017 Apr; 62(5):539-547. PubMed ID: 28123175
[TBL] [Abstract][Full Text] [Related]
37. Cellular functions of cardiolipin in yeast.
Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
[TBL] [Abstract][Full Text] [Related]
38. Tafazzin splice variants and mutations in Barth syndrome.
Kirwin SM; Manolakos A; Barnett SS; Gonzalez IL
Mol Genet Metab; 2014 Jan; 111(1):26-32. PubMed ID: 24342716
[TBL] [Abstract][Full Text] [Related]
39. Molecular Dynamics Analysis of Cardiolipin and Monolysocardiolipin on Bilayer Properties.
Boyd KJ; Alder NN; May ER
Biophys J; 2018 May; 114(9):2116-2127. PubMed ID: 29742405
[TBL] [Abstract][Full Text] [Related]
40. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
